MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes

Name: MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

metastatic cancer, metastatic renal cancer, metastatic melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 162445
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.